Across TCGA pan-cancer cohorts, FABP5P5 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of FABP5P5’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where FABP5P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FABP5P5 is over-expressed in tumor.
KIRC are the cancer types where FABP5P5 tumor–normal differential expression is most reproducible.